AI Can Boost Early Diagnosis Of Liver Disease: Study

New Delhi: Artificial Intelligence (AI) can accurately detect early-stage metabolic-associated steatotic liver disease (MASLD) by using electronic health records, finds a study.

MASLD -- the world’s most common chronic liver disease with a heavy clinical burden -- occurs when fat isn’t managed properly in the liver. The global prevalence of MASLD has been increasing in recent years.

It is also often associated with other common diseases such as obesity, Type-2 diabetes, and abnormal cholesterol levels.

As the condition can quickly progress to more severe forms of liver disease, early diagnosis is crucial. However, it often goes undetected until the late stages as it remains asymptomatic in the early stages, making diagnosis challenging.

“A significant proportion of patients who meet criteria for MASLD go undiagnosed,” said lead author Ariana Stuart, from the University of Washington, US.